Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link. The previous study record content appears to be removed or hidden.
    Difference
    18%
    Check dated 2026-09-23T21:42:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new page revision v3.7.0 is added and the previous revision v3.6.6 is removed, signaling an update to the page version.
    Difference
    0.1%
    Check dated 2026-09-16T21:36:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label was updated from v3.6.5 to v3.6.6, representing a maintenance update to the page's version identifier. It does not alter the study content or user-visible features.
    Difference
    0.1%
    Check dated 2026-09-02T19:49:07.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision tag on the page has been updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov page. This reflects a minor backend update to the page rather than any change to the study details or enrollment information.
    Difference
    0.1%
    Check dated 2026-08-12T18:22:13.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4. This indicates a minor content update without changing study details.
    Difference
    0.1%
    Check dated 2026-07-28T05:37:42.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a newer release of the page. This is an internal version update and does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-06T18:17:29.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.